N-(2-{3-[(3-hydroxypyrrolidin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)naphthalene-2-carboxamide
Structure Info
- Chemspace ID
- CSSB00159265316 (In-Stock Building Blocks)
- IUPAC Name
- N-(2-{3-[(3-hydroxypyrrolidin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)naphthalene-2-carboxamide
- Mol formula
- C27H24N4O2S
- Mol weight
- 469 Da
- Catalog Number(s)
- AG-10477, CSC159265316
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.03
- Heavy atoms count
- 34
- Rotatable bond count
- 5
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.185
- Polar surface area (Å)
- 70
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 2
![Chemical structure of N-(2-{3-[(3-hydroxypyrrolidin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)naphthalene-2-carboxamide (C27H24N4O2S) - CSSB00159265316](/st/structure/200/c11cf3219dd5d1c18bb518745dcefd49/OC1CCN%2528CC2%253DCSC3%253DNC%2528%253DCN23%2529C2%253DCC%253DCC%253DC2NC%2528%253DO%2529C2%253DCC3%253DCC%253DCC%253DC3C%253DC2%2529C1.png "C27H24N4O2S")
- Zoom the structure
- CSSB00159265316
Items Overall 4 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 100 mg | 310.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 250 mg | 550.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 500 mg | 890.00 | |
| Angel Pharmatech Ltd. | 10 days | China To: | 97 | 1 g | 1,425.00 | |
Description: CAS: 1001908-89-9 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of N-[2-(3-{[(3R)-3-hydroxypyrrolidin-1-yl]methyl}imidazo[2,1-b][1,3]thiazol-6-yl)phenyl]naphthalene-2-carboxamide - CSSB00159268979](/st/structure/200/0c6a7b029d235fa759a56ba5352f4230/O%255BC%2540%2540H%255D1CCN%2528CC2%253DCSC3%253DNC%2528%253DCN23%2529C2%253DCC%253DCC%253DC2NC%2528%253DO%2529C2%253DCC3%253DCC%253DCC%253DC3C%253DC2%2529C1.png)
Similarity Analogs
![Chemical structure of 3,4,5-trimethoxy-N-(2-{3-[(piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)benzamide - CSSB00016988636](/st/structure/200/da44053f94392768645422cd07aa2201/COC1%253DCC%2528%253DCC%2528OC%2529%253DC1OC%2529C%2528%253DO%2529NC1%253DCC%253DCC%253DC1C1%253DCN2C%2528CN3CCNCC3%2529%253DCSC2%253DN1.png)
![Chemical structure of 3,4,5-trimethoxy-N-(2-{3-[(piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)benzamide; trifluoroacetic acid - CSSB02125605435](/st/structure/200/e2102fed902436bca0910772fd535f16/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.COC1%253DCC%2528%253DCC%2528OC%2529%253DC1OC%2529C%2528%253DO%2529NC1%253DCC%253DCC%253DC1C1%253DCN2C%2528CN3CCNCC3%2529%253DCSC2%253DN1.png)
![Chemical structure of N-(2-{3-[(piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)quinoxaline-2-carboxamide - CSSB00020628925](/st/structure/200/b98064a54fa22f6e499804fee0c48971/O%253DC%2528NC1%253DCC%253DCC%253DC1C1%253DCN2C%2528CN3CCNCC3%2529%253DCSC2%253DN1%2529C1%253DNC2%253DCC%253DCC%253DC2N%253DC1.png)
![Chemical structure of N-(2-{3-[(piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)quinoxaline-2-carboxamide hydrochloride - CSSB00015193880](/st/structure/200/af3c2467b73b179af5abb84cf2993562/Cl.O%253DC%2528NC1%253DCC%253DCC%253DC1C1%253DCN2C%2528CN3CCNCC3%2529%253DCSC2%253DN1%2529C1%253DNC2%253DCC%253DCC%253DC2N%253DC1.png)
![Chemical structure of N-(2-{3-[(piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)quinoxaline-2-carboxamide dihydrochloride - CSSB00159323586](/st/structure/200/c2036ea323133e429f9899c892fa0e43/Cl.Cl.O%253DC%2528NC1%253DCC%253DCC%253DC1C1%253DCN2C%2528CN3CCNCC3%2529%253DCSC2%253DN1%2529C1%253DNC2%253DCC%253DCC%253DC2N%253DC1.png)
![Chemical structure of N-(2-{3-[(piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)quinoxaline-2-carboxamide tetrahydrochloride - CSSB00159320538](/st/structure/200/ffad72678e0dcb601f2272e673df56c6/Cl.Cl.Cl.Cl.O%253DC%2528NC1%253DCC%253DCC%253DC1C1%253DCN2C%2528CN3CCNCC3%2529%253DCSC2%253DN1%2529C1%253DNC2%253DCC%253DCC%253DC2N%253DC1.png)
